Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: Stratification and integration of immune protection against the transmission of sexually transmitted infections

Journal of Reproductive Immunology

Volumn 88, Issue 2, 2011, Pages 185-194

  Hickey, D K ^a   Patel, M V ^a   Fahey, J V ^a   Wira, C R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Adaptive immunity; Antimicrobials; Female reproductive tract; Innate immunity

Indexed keywords

BETA DEFENSIN; CATHELICIDIN; CYTOKINE; ELAFIN; ESTRADIOL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYSOZYME; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MUCIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROGESTERONE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SEX HORMONE; TRANSFORMING GROWTH FACTOR BETA;

ACIDITY; ADAPTIVE IMMUNITY; AFRICA; ANTIGEN PRESENTING CELL; CANDIDA ALBICANS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE TRANSMISSION; EPITHELIUM CELL; FEMALE GENITAL SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MALE HOMOSEXUAL; MENSTRUAL CYCLE; MUCOSA; MUCUS; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SEXUALLY TRANSMITTED DISEASE; STROMA CELL; TH1 CELL; TH17 CELL; TH2 CELL;

ADAPTIVE IMMUNITY; ANIMALS; FEMALE; GENITALIA, FEMALE; HUMANS; IMMUNITY, INNATE; INFECTION; MUCOUS MEMBRANE; PREGNANCY; SEXUALLY TRANSMITTED DISEASES;

EID: 79952699341     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2011.01.005     Document Type: Review

References (89)

1. Ahmed N., et al. Suppression of human immunodeficiency virus type 1 replication in macrophages by commensal bacteria preferentially stimulating Toll-like receptor 4. J. Gen. Virol. 2010, 91:2804-2813.
2. Arruvito L., et al. Expansion of CD4+ CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol. 2007, 178:2572-2578.
3. Bazer F.W., et al. Interferons and uterine receptivity. Semin. Reprod. Med. 2009, 27:90-102.
4. Bélec L., Pillot J. Raped women and HIV infection. J. Forensic Sci. 1995, 40:925-926.
5. Black C.A., et al. Vaginal mucosa serves as an inductive site for tolerance. J. Immunol. 2000, 165:5077-5083.
6. Bloomfield S.E., Lopez C. Herpes infections in the immunosuppressed host. Ophthalmology 1980, 87:1226-1235.
7. Capaldo C.T., Nusrat A. Cytokine regulation of tight junctions. Biochim. Biophys. Acta 2009, 1788:864-871.
8. Carolan E.J., et al. Cytokine-induced neutrophil transepithelial migration is dependent upon epithelial orientation. Am. J. Respir. Cell. Mol. Biol. 1997, 17:727-732.
9. Cassol E., et al. Macrophage polarization and HIV-1 infection. J. Leukoc. Biol. 2010, 87:599-608.
10. Chehimi J., et al. HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages. J. Leukoc. Biol. 2003, 74:757-763.
11. Coleman K.D., et al. Estradiol modulation of hepatocyte growth factor by stromal fibroblasts in the female reproductive tract. Fertil. Steril. 2009, 92:1107-1109.
12. Critchley H.O.D., et al. Antiprogestins as a model for progesterone withdrawal. Steroids 2003, 68:1061-1068.
13. Domino S.E., et al. Cervical mucins carry alpha(1,2)fucosylated glycans that partly protect from experimental vaginal candidiasis. Glycoconj. J. 2009, 26:1125-1134.
14. Elstein M. Functions and physical properties of mucus in the female genital tract. Br. Med. Bull. 1978, 34:83-88.
15. Eriksson M., et al. Endogenous transforming growth factor-beta inhibits toll-like receptor mediated activation of human uterine natural killer cells. Am. J. Reprod. Immunol. 2006, 56:321-328.
16. Fahey J.V., et al. Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum. Reprod. 2005, 20:1439-1446.
17. Fahey J.V., Wira C.R. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J. Infect. Dis. 2002, 185:1606-1613.
18. Fahey J.V., et al. Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture. Mucosal Immunol. 2008, 1:317-325.
19. Feinen B., et al. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol. 2010, 3:312-321.
20. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3:710-720.
21. Ghosh M., et al. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One 2010, 5:e11366.
22. Gipson I.K., et al. Mucin genes expressed by human female reproductive tract epithelia. Biol. Reprod. 1997, 56:999-1011.
23. Givan A.L., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of Fallopian tube, uterus, cervix, and vagina. Am. J. Reprod. Immunol. 1997, 38:350-359.
24. Gockel C.M., et al. Influence of the murine oestrous cycle on the induction of mucosal immunity. Am. J. Reprod. Immunol. 2003, 50:369-379.
25. Grant K.S., Wira C.R. Effect of mouse uterine stromal cells on epithelial cell transepithelial resistance (TER) and TNF alpha and TGF beta release in culture. Biol. Reprod. 2003, 69:1091-1098.
26. Grant-Tschudy K.S., Wira C.R. Paracrine mediators of mouse uterine epithelial cell transepithelial resistance in culture. J. Reprod. Immunol. 2005, 67:1-12.
27. Gringhuis S.I., et al. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 2010, 11:419-426.
28. Haase A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464:217-223.
29. Haddad S.N., Wira C.R. Keratinocyte growth factor stimulates macrophage inflammatory protein 3alpha and keratinocyte-derived chemokine secretion by mouse uterine epithelial cells. Am. J. Reprod. Immunol. 2010, 64:197-211.
30. Hladik F., et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007, 26:257-270.
31. Hocini H., et al. Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin. Diagn. Lab. Immunol. 2000, 7:515-518.
32. Holtmeier W., Kabelitz D. gammadelta T cells link innate and adaptive immune responses. Chem. Immunol. Allergy 2005, 86:151-183.
33. Hughes G.C., et al. Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J. Immunol. 2008, 180:2029-2033.
34. Iijima N., et al. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J. Exp. Med. 2008, 205:3041-3052.
35. Johansson E., et al. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect. Immun. 1998, 66:514-520.
36. Johansson E.L., et al. Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 1999, 96:272-277.
37. Kamat B.R., Isaacson P.G. The immunocytochemical distribution of leukocytic subpopulations in human endometrium. Am. J. Pathol. 1987, 127:66-73.
38. Kaushic C., et al. Polymeric immunoglobulin A receptor in the rodent female reproductive tract: influence of estradiol in the vagina and differential expression of messenger ribonucleic acid during estrous cycle. Biol. Reprod. 1997, 57:958-966.
39. Kaushic C., et al. Regulation of polymeric immunoglobulin A receptor messenger ribonucleic acid expression in rodent uteri: effect of sex hormones. Endocrinology 1995, 136:2836-2844.
40. Kaushic C., Wira C.R. IgA and reproductive tract immunity. Mucosal Immune Defense: Immunoglobulin A 2008, 291-320. Kluwer Academic/Plenum Publisher, New York. C. Kaetzel (Ed.).
41. Kaushic C., et al. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 2000, 68:4207-4216.
42. Kayisli U.A., et al. Uterine chemokines in reproductive physiology and pathology. Am. J. Reprod. Immunol. 2002, 47:213-221.
43. Keller M.J., et al. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS 2007, 21:467-476.
44. Keller M.J., et al. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial. J. Infect. Dis. 2006, 193:27-35.
45. Knee R.A., et al. Transport of IgG across the blood-luminal barrier of the male reproductive tract of the rat and the effect of estradiol administration on reabsorption of fluid and IgG by the epididymal ducts. Biol. Reprod. 2005, 73:688-694.
46. Kutteh W.H., Mestecky J. Secretory immunity in the female reproductive tract. Am. J. Reprod. Immunol. 1994, 31:40-46.
47. Lai S.K., et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J. Virol. 2009, 83:11196-11200.
48. Le Bon A., Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 2002, 14:432-436.
49. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 2003, 3:361-370.
50. Ming L., et al. Purification of antimicrobial factors from human cervical mucus. Hum. Reprod. 2007, 22:1810-1815.
51. Mor G., Cardenas I. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 2010, 63:425-433.
52. Mselle T.F., et al. Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12. J. Virol. 2009, 83:11188-11195.
53. Mselle T.F., et al. Unique characteristics of NK cells throughout the human female reproductive tract. Clin. Immunol. 2007, 124:69-76.
54. Nakanishi Y., et al. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009, 462:510-513.
55. Nakashima A., et al. Accumulation of IL-17-positive cells in decidua of inevitable abortion cases. Am. J. Reprod. Immunol. 2010, 64:4-11.
56. Nazli A., et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 2010, 6:e1000852.
57. Nishimura H., et al. Intraepithelial gamma/delta T cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type 2. J. Virol. 2004, 78:4927-4930.
58. Ochiel D.O., et al. Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands. J. Leukoc. Biol. 2010, 88:435-444.
59. Ochiel D.O., et al. Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells. PLoS One 2010, 5:e14306.
60. Pivarcsi A., et al. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human beta-defensin-2 in vaginal epithelial cells. Microb. Infect. 2005, 7:1117-1127.
61. Quesnel A., et al. Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women. J. Immunol. Methods 1997, 202:153-161.
62. Ravel, J., et al., in press. Microbes and health sackler colloquium: vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U.S.A., http://www.pnas.org/cgi/doi/10.1073/pnas.1002611107.
63. Sallusto F., Lanzavecchia A. The instructive role of dendritic cells on T-cell responses. Arthritis Res. 2002, 4(Suppl. 3):S127-S132.
64. Schaefer T.M., et al. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist Poly(I:C). J. Immunol. 2005, 174:992-1002.
65. Schumacher G.F.B. Soluble proteins in cervical mucus. The Biology of the Cervix 1973, 201-233. The University of Chicago Press, Chicago. R.J. Blandau, K. Moghissi (Eds.).
66. Scurlock, A.M., et al., in press. IL-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect. Immun., doi:10.1128/IAI.00984-10.
67. Selsted M.E., Ouellette A.J. Defensins in granules of phagocytic and non-phagocytic cells. Trends Cell Biol. 1995, 5:114-119.
68. Shen R., et al. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 Infection. J. Virol. 2009, 83:3258-3267.
69. Starkey P.M., et al. Variation during the menstrual cycle of immune cell populations in human endometrium. Eur. J. Obstet. Gynecol. Reprod. Biol. 1991, 39:203-207.
70. Sullivan D.A., et al. Variations in the levels of secretory component in human uterine fluid during the menstrual cycle. J. Steroid Biochem. 1984, 20:509-513.
71. Sullivan D.A., et al. Steroid hormone regulation of free secretory component in the rat uterus. Immunology 1983, 49:379-386.
72. Sullivan D.A., Wira C.R. Hormonal regulation of immunoglobulins in the rat uterus: uterine response to multiple estradiol treatments. Endocrinology 1984, 114:650-658.
73. Tomee J.F., et al. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J. Infect. Dis. 1997, 176:740-747.
74. Trifonova R.T., et al. Polyanionic microbicides modify Toll-like receptor-mediated cervicovaginal immune responses. Antimicrob. Agents Chemother. 2009, 53:1490-1500.
75. Trinchieri G. Type I interferon: friend or foe?. J. Exp. Med. 2010, 207:2053-2063.
76. U.N.A.I.D.S. AIDS epidemic update 2008, Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO), Geneva, Switzerland.
77. Verani A., Lusso P. Chemokines as natural HIV antagonists. Curr. Mol. Med. 2002, 2:691-702.
78. Vigil P., et al. Scanning electron and light microscopy study of the cervical mucus in women with polycystic ovary syndrome. J. Electron Microsc. (Tokyo) 2009, 58:21-27.
79. W.H.O. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates 2001, World Health Organisation (WHO), Geneva.
80. White H.D., et al. CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J. Immunol. 1997, 158:3017-3027.
81. Wilson J. Managing recurrent bacterial vaginosis. Sex. Transm. Infect. 2004, 80:8-11.
82. Wira C.R., Fahey J.V. The innate immune system: gatekeeper to the female reproductive tract. Immunology 2004, 111:13-15.
83. Wira C.R., et al. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am. J. Rep. Immunol. 2010, 63:544-565.
84. Wira C.R., et al. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. 2005, 206:306-335.
85. Wira, C.R., et al., 2010b. Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus. Mucosal Immunol., doi:10.1038/mi.2010.72.
86. Wira C.R., Sullivan D.A. Estradiol and progesterone regulation of IgA, IgG and secretory component in cervico-vaginal secretions of the rat. Biol. Reprod. 1985, 32:90-95.
87. Witkin S.S., et al. Bacterial flora of the female genital tract: function and immune regulation. Best Pract. Res. Clin. Obstet. Gynaecol. 2007, 21:347-354.
88. Yeaman G.R., et al. CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking. Immunology 2001, 102:434-440.
89. Yeaman G.R., et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J. Leukoc. Biol. 1997, 61:427-435.